{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T23:10:20Z","timestamp":1787613020317,"version":"build-2736575974"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Krabbe disease (KD) is a rapidly progressive neurodegenerative disorder caused by \u03b2-galactocerebrosidase deficiency. While KD has been added to the Recommended Uniform Screening Panel (RUSP), only 15 states have an active KD newborn screening (NBS) program. It is uncertain at what rate states will adopt RUSP recommendations, with a frequently cited barrier being the absence of investigations addressing the impact of hematopoietic stem cell transplantation (HSCT) on quality-of-life.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We developed a 90-minute caregiver interview to gather qualitative and quantitative data (including the validated Leukodystrophy Quality-of-Life Assessment \u2013 LQLA) evaluating patient\/family-centered outcomes of HSCT. The interview was designed to explore the following: 1) disease burden on the patient; 2) physical burden on the caregiver; and 3) emotional\/social burden on the caregiver. Comparisons were made between children not transplanted\/transplanted late and children transplanted early. Infantile KD (IKD) and late infantile KD (LIKD) were analyzed independently.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Forty caregivers participated (non-transplanted\/transplanted late: IKD\u2009=\u200919, LIKD\u2009=\u20097; transplanted early: IKD\u2009=\u200910, LIKD\u2009=\u20094). Analysis of the LQLA revealed a relative reduction in disease burden in both IKD and LIKD groups who were transplanted early. Specifically, the early transplanted cohorts achieved statistically significant higher overall scores on the LQLA, as well as better scores in various subcategories in comparison to their non-transplanted\/transplanted late counterparts. For IKD, analysis of Likert scale and weighted analysis demonstrated a tendency towards decreased physical burden on caregivers of children transplanted early. Although all groups experienced significant social\/emotional burdens, caregivers of IKD transplanted early benefitted from improved sleep, mental health, and familial\/spousal relationships compared to IKD non-transplanted\/transplanted late.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study provides convincing evidence that HSCT improves quality-of-life and reduces caregiver burden in IKD. The evidence is somewhat less clear for LIKD due to the small LIKD sample size. This data will be critical in the decision-making process for states not currently screening for KD but debating the addition of KD to their NBS panels. Lastly, it will allow families to weigh the risks and benefits of HSCT more confidently when contemplating the life-altering decision of whether to proceed with transplantation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-025-04176-3","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T12:51:22Z","timestamp":1767790282000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Caregiver-reported disease burden in Krabbe disease: evaluating outcomes of hematopoietic stem cell transplantation"],"prefix":"10.1186","volume":"21","author":[{"given":"Nicholas Alexander","family":"Bascou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Skyler","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patti","family":"Engel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Melchior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Orchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacy","family":"Pike-Langenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"4176_CR1","doi-asserted-by":"crossref","unstructured":"Suzuki K. Globoid cell leukodystrophy (Krabbe\u2019s disease): update. J Child Neurol. 2003;18(9):595\u2013603.","DOI":"10.1177\/08830738030180090201"},{"key":"4176_CR2","doi-asserted-by":"crossref","unstructured":"Sakai N. Pathogenesis of leukodystrophy for Krabbe disease: molecular mechanism and clinical treatment. Brain and Devel. 2009;31(7):485\u201387.","DOI":"10.1016\/j.braindev.2009.03.001"},{"key":"4176_CR3","doi-asserted-by":"crossref","unstructured":"Wenger DA, Rafi MA, Luzi P, Datto J, Costantino-Ceccarini E. Krabbe disease: genetic aspects and progress toward therapy. Mol Genet Metab. 2000;70(1):1\u20139.","DOI":"10.1006\/mgme.2000.2990"},{"key":"4176_CR4","unstructured":"Orsini JJ, Escolar ML, Wasserstein MP, Caggana M. Krabbe disease. GeneReviews. 2018."},{"key":"4176_CR5","doi-asserted-by":"crossref","unstructured":"Zhao S, Zhan X, Wang Y, Ye J, Han L, Qiu W, Gao X, Gu X, Zhang H. Large-scale study of clinical and biochemical characteristics of Chinese patients diagnosed with Krabbe disease. Clin Genet. 2018;93(2):248\u201354.","DOI":"10.1111\/cge.13071"},{"key":"4176_CR6","doi-asserted-by":"crossref","unstructured":"Bascou N, DeRenzo A, Poe MD, Escolar ML. A prospective natural history study of Krabbe disease in a patient cohort with onset between 6 months and 3 years of life. Orphanet J Rare Dis. 2018 Aug, 9;13(1):126.","DOI":"10.1186\/s13023-018-0872-9"},{"key":"4176_CR7","doi-asserted-by":"crossref","unstructured":"Beltran-Quintero ML, Bascou NA, Poe MD, Wenger DA, Saavedra-Matiz CA, Nichols MJ, Escolar ML. Early progression of Krabbe disease in patients with symptom onset between 0 and 5 months. Orphanet J Rare Dis. 2019 Feb, 18;14(1):46.","DOI":"10.1186\/s13023-019-1018-4"},{"key":"4176_CR8","doi-asserted-by":"crossref","unstructured":"Greco MR, Lopez MA, Beltran-Quintero ML, Tuc Bengur E, Poe MD, Escolar ML. Infantile Krabbe disease (0-12 months), progression, and recommended endpoints for clinical trials. Ann of Clin and Transl Neurol. 2024 Dec;11(12):3064\u201380.","DOI":"10.1002\/acn3.52114"},{"issue":"6","key":"4176_CR9","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1038\/s41436-020-0764-y","volume":"22","author":"AJ Guenzel","year":"2020","unstructured":"Guenzel AJ, Turgeon CT, Nickander KK, White AL, Peck DS, Pino GB, Studinski AL, Prasad VK, Kurtzberg J, Escolar ML, Lasio ML. The critical role of psychosine in screening, diagnosis, and monitoring of Krabbe disease. Genet in Med. 2020 Jun, 1;22(6):1108\u201318.","journal-title":"Genet in Med"},{"issue":"5","key":"4176_CR10","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1007\/s10545-015-9822-z","volume":"38","author":"CT Turgeon","year":"2015","unstructured":"Turgeon CT, Orsini JJ, Sanders KA, Magera MJ, Langan TJ, Escolar ML, Duffner P, Oglesbee D, Gavrilov D, Tortorelli S, Rinaldo P. Measurement of psychosine in dried blood spots-a possible improvement to newborn screening programs for Krabbe disease. J Inherited Metabolic Disease. 2015 Sep;38(5):923\u201329.","journal-title":"J Inherited Metabolic Disease"},{"issue":"3","key":"4176_CR11","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.ymgme.2017.05.015","volume":"121","author":"ML Escolar","year":"2017","unstructured":"Escolar ML, Kiely BT, Shawgo E, Hong X, Gelb MH, Orsini JJ, Matern D, Poe MD. Psychosine, a marker of Krabbe phenotype and treatment effect. Mol Genet And Metab. 2017 Jul, 1;121(3):271\u201378.","journal-title":"Mol Genet And Metab"},{"key":"4176_CR12","doi-asserted-by":"crossref","unstructured":"Bascou NA, Beltran-Quintero ML, Escolar ML. Pathogenic variants in GALC gene correlate with late onset Krabbe disease and vision loss: case series and review of literature. Front Neurol. 2020 Oct, 15;11:563724.","DOI":"10.3389\/fneur.2020.563724"},{"key":"4176_CR13","unstructured":"Wenger DA, Suzuki K, Suzuki Y, Suzuki K. Galactosylceramide lipidosis: globoid cell leukodystrophy (Krabbe disease).in: Scriver CR, Sly WS, Childs B, The metabolic and molecular bases of inherited disease. 8th. New York: McGraw-Hill; 2001. p. 3669\u201394, et al.editors."},{"issue":"1","key":"4176_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.pediatrneurol.2008.08.011","volume":"40","author":"PK Duffner","year":"2009","unstructured":"Duffner PK, Jalal K, Carter RL. The Hunter\u2019s hope Krabbe family database. Pediatr Neurol. 2009;40(1):13\u201318.","journal-title":"Pediatr Neurol"},{"key":"4176_CR15","doi-asserted-by":"crossref","unstructured":"Duffner PK, Barczykowski A, Jalal K, Yan L, Kay DM, Carter RL. Early infantile Krabbe disease: results of the world-wide Krabbe registry. Pediatr Neurol. 2011;45(3):141\u201348.","DOI":"10.1016\/j.pediatrneurol.2011.05.007"},{"key":"4176_CR16","unstructured":"Wenger DA, Escolar ML, Luzi P, Rafi MA. Krabbe disease (globoid cell leukodystrophy). Scriver\u2019s the Online Metabolic and Mol Bases of Inherited Disease (OMMBID). 2013."},{"key":"4176_CR17","doi-asserted-by":"crossref","unstructured":"Duffner PK, Barczykowski A, Kay DM, Jalal K, Yan L, Abdelhalim A, Gill S, Gill AL, Carter R. Later onset phenotypes of Krabbe disease: results of the world-wide registry. Pediatr Neurol. 2012;46(5):298\u2013306.190.","DOI":"10.1016\/j.pediatrneurol.2012.02.023"},{"issue":"2","key":"4176_CR18","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s10048-016-0476-2","volume":"17","author":"Y Shao","year":"2016","unstructured":"Shao Y, Choquet K, Piana RL, et al. B. Mutations in GALC cause late-onset Krabbe disease with predominant cerebellar ataxia. Neurogenetics. 2016;17(2):137\u201341.","journal-title":"Neurogenetics"},{"issue":"5","key":"4176_CR19","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s10545-012-9560-4","volume":"36","author":"R Debs","year":"2013","unstructured":"Debs R, Froissart R, Aubourg P, Papeix C, Douillard C, Degos B, Fontaine B, Audoin B, Lacour A, Said G, Vanier MT. Krabbe disease in adults: phenotypic and genotypic update from a series of 11 cases and a review. J Inherited Metabolic Disease: Off J Soc for the Study of Inborn Errors of Metab. 2013 Sep;36(5):859\u201368.","journal-title":"J Inherited Metabolic Disease: Off J Soc For The Study Of Inborn Errors Of Metab"},{"issue":"4","key":"4176_CR20","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/jns.12511","volume":"27","author":"E Forbes","year":"2022","unstructured":"Forbes E, Smith K, Petluru M, Nystrom J, Fridman V. Adult-onset Krabbe disease presenting as isolated sensorimotor demyelinating polyneuropathy: a case report. J Peripheral Nerv System. 2022 Dec;27(4):320\u201324.","journal-title":"J Peripheral Nerv System"},{"key":"4176_CR21","doi-asserted-by":"publisher","first-page":"1010150","DOI":"10.3389\/fneur.2022.1010150","volume":"13","author":"Y Wang","year":"2022","unstructured":"Wang Y, Wang SY, Li K, Zhu YL, Xia K, Sun DD, Ai WL, Fu XM, Ye QR, Li J, Chen HZ. Adult-onset Krabbe disease presenting with progressive myoclonic epilepsy and asymmetric occipital lesions: a case report. Front Neurol. 2022 Oct, 21;13:1010150.","journal-title":"Front Neurol"},{"issue":"1","key":"4176_CR22","first-page":"e15","volume":"11","author":"J Dur\u00e3es","year":"2021","unstructured":"Dur\u00e3es J, Salsano E, Mac\u00e1rio MD. Adult-onset Krabbe disease: the importance of a systematic approach to brain MRI findings. Neurol: Clin Pract. 2021 Feb;11(1):e15\u20137.","journal-title":"Neurol: Clin Pract"},{"issue":"13","key":"4176_CR23","first-page":"1719","volume":"137","author":"IC Yoon","year":"2021","unstructured":"Yoon IC, Bascou NA, Poe MD, Szabolcs P, Escolar ML. Long-term neurodevelopmental outcomes of hematopoietic stem cell transplantation for late-infantile Krabbe disease. Blood, The J Am Soc of Hematol. 2021 Apr, 1;137(13):1719\u201330.","journal-title":"Blood, The J Am Soc Of Hematol"},{"issue":"13","key":"4176_CR24","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1212\/WNL.0000000000004418","volume":"89","author":"MD Wright","year":"2017","unstructured":"Wright MD, Poe MD, DeRenzo A, Haldal S, Escolar ML. Developmental outcomes of cord blood transplantation for Krabbe disease: a 15-year study. Neurology. 2017 Sep, 26;89(13):1365\u201372.","journal-title":"Neurology"},{"key":"4176_CR25","doi-asserted-by":"crossref","unstructured":"Page KM, Ream MA, Rangarajan HG, Galindo R, Mian AY, Ho ML, Provenzale J, Gustafson KE, Rubin J, Shenoy S, Kurtzberg J. Benefits of newborn screening and hematopoietic cell transplant in infantile Krabbe disease. Blood Adv. 2022 May, 10;6(9):2947\u201356.","DOI":"10.1182\/bloodadvances.2021006094"},{"key":"4176_CR26","doi-asserted-by":"crossref","unstructured":"Allewelt H, Taskindoust M, Troy J, Page K, Wood S, Parikh S, Prasad VK, Kurtzberg J. Long-term functional outcomes after hematopoietic stem cell transplant for early infantile Krabbe disease. Biol of Blood and Marrow Transplant. 2018 Nov, 1;24(11):2233\u201338.","DOI":"10.1016\/j.bbmt.2018.06.020"},{"issue":"20","key":"4176_CR27","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1056\/NEJMoa042604","volume":"352","author":"ML Escolar","year":"2005","unstructured":"Escolar ML, Poe MD, Provenzale JM, Richards KC, Allison J, Wood S, Wenger DA, Pietryga D, Wall D, Champagne M, Morse R. Transplantation of umbilical-cord blood in babies with infantile Krabbe\u2019s disease. N Engl J Med. 2005 May, 19;352(20):2069\u201381.","journal-title":"N Engl J Med"},{"issue":"3","key":"4176_CR28","doi-asserted-by":"publisher","first-page":"e879","DOI":"10.1542\/peds.2006-0747","volume":"118","author":"ML Escolar","year":"2006","unstructured":"Escolar ML, Poe MD, Martin HR, Kurtzberg J. A staging system for infantile Krabbe disease to predict outcome after unrelated umbilical cord blood transplantation. Pediatrics. 2006;118(3):e879\u201389.","journal-title":"Pediatrics"},{"issue":"12","key":"4176_CR29","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/gim.2016.35","volume":"18","author":"MP Wasserstein","year":"2016","unstructured":"Wasserstein MP, Andriola M, Arnold G, Aron A, Duffner P, Erbe RW, Escolar ML, Estrella L, Galvin-Parton P, Iglesias A, Kay DM. Clinical outcomes of children with abnormal newborn screening results for Krabbe disease in New York state. Genet in Med. 2016 Dec;18(12):1235\u201343.","journal-title":"Genet in Med"},{"key":"4176_CR30","doi-asserted-by":"publisher","first-page":"237437352413094","DOI":"10.1177\/23743735241309470","volume":"12","author":"Y Koto","year":"2025","unstructured":"Koto Y, Yamashita W, Kitamura K, Sakai N. Experiences of patients and families living with Krabbe Disease. J Patient Exper. 2025 Jan;12:23743735241309470.","journal-title":"J Patient Exper"},{"issue":"7","key":"4176_CR31","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.11124\/JBIES-23-00303","volume":"22","author":"Y Koto","year":"2024","unstructured":"Koto Y, Ueki S, Yamakawa M, Sakai N. Experiences of patients with metachromatic leukodystrophy, adrenoleukodystrophy, or Krabbe disease and the experiences of their family members: a qualitative systematic review. JBI Evidence Synth. 2024 Jul, 1;22(7):1262\u2013302.","journal-title":"JBI Evidence Synth"},{"key":"4176_CR32","unstructured":"Kemper AR, Lam KK, Ream M, DiCostanzo K, Grosse SD, Prosser LA, Rose A, Ojodu J, Jones E, Comeau AM, Tanksley S. Expedited evidence-based review of newborn screening for Krabbe disease final report: February 1. 2024."},{"issue":"4","key":"4176_CR33","doi-asserted-by":"publisher","first-page":"e2024069152","DOI":"10.1542\/peds.2024-069152","volume":"155","author":"MA Ream","year":"2025","unstructured":"Ream MA, Lam WK, Grosse SD, Ojodu J, Jones E, Prosser LA, Rose AM, Marie Comeau A, Tanksley S, DiCostanzo KP, Kemper AR. Evidence and recommendation for infantile Krabbe disease newborn screening. Pediatrics. 2025 Apr, 1;155(4):e2024069152.","journal-title":"Pediatrics"},{"issue":"1","key":"4176_CR34","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/ijns10010010","volume":"10","author":"D Matern","year":"2024","unstructured":"Matern D, Basheeruddin K, Klug TL, McKee G, Edge PU, Hall PL, Kurtzberg J, Orsini JJ. Newborn screening for Krabbe disease: status quo and recommendations for improvements. Int J Neonatal Screening. 2024 Jan, 28;10(1):10.","journal-title":"Int J Neonatal Screening"},{"issue":"3","key":"4176_CR35","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/ijns4030023","volume":"4","author":"MH Gelb","year":"2018","unstructured":"Gelb MH. Newborn screening for lysosomal storage diseases: methodologies, screen positive rates, normalization of datasets, second-tier tests, and post-analysis tools. Int J Neonatal Screen. 2018;4(3):23.","journal-title":"Int J Neonatal Screen"},{"key":"4176_CR36","first-page":"101572","volume":"29","author":"PL Hall","year":"2025","unstructured":"Hall PL, White AL, Peck D, Pino G, Studinski A, Gavrilov D, Oglesbee D, Schultz MJ, Tortorelli S, Matern D. Two-tiered newborn screening for infantile Krabbe disease allows for timely treatment initiation and avoids false positive results. Genet in Med. 2025 Aug;29:101572.","journal-title":"Genet in Med"},{"key":"4176_CR37","doi-asserted-by":"crossref","unstructured":"Peterson L, Siemon A, Olewiler L, McBride KL, Allain DC. A qualitative assessment of parental experiences with false-positive newborn screening for Krabbe disease. J Genetic Couns. 2022 Feb;31(1):252\u201360.","DOI":"10.1002\/jgc4.1480"},{"key":"4176_CR38","doi-asserted-by":"crossref","unstructured":"Kanungo S, Vergano SA, Clark T, Madani R, Schott M, Couch K, Villela R, White N. Krabbe disease-to add or not to newborn screening? OBM Genet. 2024 Jan;8(1):1\u20139.","DOI":"10.21926\/obm.genet.2401210"},{"key":"4176_CR39","doi-asserted-by":"crossref","unstructured":"Schrier Vergano SA, Kanungo S, Arnold G. Making decisions about Krabbe disease newborn screening. Pediatrics. 2022 Apr, 1;149(4).","DOI":"10.1542\/peds.2021-053175"},{"key":"4176_CR40","doi-asserted-by":"crossref","unstructured":"Kurtzberg J, Matern D, Orsini JJ, Gelb M, Pike-Langenfeld S, Brackbill L, Grantham A, Steyermark AC. Making decisions about Krabbe disease newborn screening. Pediatrics. 2022 Aug, 1;150(2).","DOI":"10.1542\/peds.2022-057888A"},{"issue":"1","key":"4176_CR41","first-page":"47","volume":"47","author":"TJ Langan","year":"2019","unstructured":"Langan TJ, Barczykowski A, Jalal K, Sherwood L, Allewelt H, Kurtzberg J, Carter RL. Survey of quality of life, phenotypic expression, and response to treatment in Krabbe leukodystrophy. JIMD Rep. 2019 May;47(1):47\u201354.","journal-title":"JIMD Rep"},{"issue":"3","key":"4176_CR42","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s11136-020-02688-y","volume":"30","author":"YS Feng","year":"2021","unstructured":"Feng YS, Kohlmann T, Janssen MF, Buchholz I. Psychometric properties of the EQ-5D-5L: a systematic review of the literature. Qual of Life Res. 2021 Mar;30(3):647\u201373.","journal-title":"Qual Of Life Res"},{"issue":"11","key":"4176_CR43","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1002\/jnr.23891","volume":"94","author":"ML Escolar","year":"2016","unstructured":"Escolar ML, West T, Dallavecchia A, Poe MD, LaPoint K. Clinical management of K rabbe disease. J Neurosci Res. 2016, Nov;94(11):1118\u201325.","journal-title":"J Neurosci Res"},{"key":"4176_CR44","doi-asserted-by":"crossref","unstructured":"Bascou NA, Marcos MC, Beltran Quintero ML, Roosen-Marcos MC, Cladis FP, Poe MD, Escolar ML. General anesthesia safety in progressive leukodystrophies: a retrospective study of patients with Krabbe disease and metachromatic leukodystrophy. Pediatr Anesth. 2019 Oct;29(10):1053\u201359.","DOI":"10.1111\/pan.13714"},{"key":"4176_CR45","doi-asserted-by":"crossref","unstructured":"Wenger DA, Luzi P, Rafi MA. Advances in the diagnosis and treatment of Krabbe disease. Int J Neonatal Screening. 2021 Aug, 18;7(3):57.","DOI":"10.3390\/ijns7030057"},{"issue":"1","key":"4176_CR46","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.ymthe.2023.11.014","volume":"32","author":"AM Bradbury","year":"2024","unstructured":"Bradbury AM, Bagel J, Swain G, Miyadera K, Pesayco JP, Assenmacher CA, Brisson B, Hendricks I, Wang XH, Herbst Z, Pyne N. Combination HSCT and intravenous AAV-mediated gene therapy in a canine model proves pivotal for translation of Krabbe disease therapy. Mol Ther. 2024 Jan, 3;32(1):44\u201358.","journal-title":"Mol Ther"},{"key":"4176_CR47","doi-asserted-by":"crossref","unstructured":"Escolar M, Vander Lugt M, Poe M, Greco M, Werling K, De Silva E, Ruiz J, Szabolcs P. P014: first-in-human phase 1\/2 trial of intravenous FBX-101 with cord blood transplantation increases GALC, brain and motor development in infantile Krabbe. Genet in Med Open. 2023 Jan, 1;1(1).","DOI":"10.1016\/j.gimo.2023.100024"},{"key":"4176_CR48","doi-asserted-by":"crossref","unstructured":"Bradbury AM, Rafi MA, Bagel JH, Brisson BK, Marshall MS, Pesayco Salvador J, Jiang X, Swain GP, Prociuk ML, ODonnell PA, Fitzgerald C. AAVrh10 gene therapy ameliorates central and peripheral nervous system disease in canine globoid cell leukodystrophy (Krabbe disease). Hum Gene Ther. 2018 Jul, 1;29(7):785\u2013801.","DOI":"10.1089\/hum.2017.151"},{"issue":"4","key":"4176_CR49","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/neup.12967","volume":"44","author":"I Ketata","year":"2024","unstructured":"Ketata I, Ellouz E. From pathological mechanisms in Krabbe disease to cutting-edge therapy: a comprehensive review. Neuropathology. 2024 Aug;44(4):255\u201377.","journal-title":"Neuropathology"},{"issue":"11","key":"4176_CR50","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1002\/jnr.23762","volume":"94","author":"SJ Spratley","year":"2016","unstructured":"Spratley SJ, Deane JE. New therapeutic approaches for Krabbe disease: the potential of pharmacological chaperones. J Neurosci Res. 2016 Nov;94(11):1203\u201319.","journal-title":"J Neurosci Res"},{"key":"4176_CR51","doi-asserted-by":"crossref","unstructured":"Del Grosso A, Carpi S, Colagiorgio L, De Sarlo M, Gagliardi M, Cecchini M. Investigating the cellular effects of GALC dosing in enzyme replacement therapy for Krabbe disease supports the role of nanomedicine. Adv Biol. 2025;e00147.","DOI":"10.1002\/adbi.202500147"},{"key":"4176_CR52","doi-asserted-by":"crossref","unstructured":"Sevin C, Barth M, Wilds A, Afriyie A, Walz M, Dillon A, Howie K, Pang F. An international study of caregiver-reported burden and quality of life in metachromatic leukodystrophy. Orphanet J Rare Dis. 2022 Sep, 2;17(1):329.","DOI":"10.1186\/s13023-022-02501-8"},{"key":"4176_CR53","doi-asserted-by":"crossref","unstructured":"Klietz M. Caregiver burden in movement disorders and neurodegenerative diseases. Brain Sci. 2022 Sep, 2;12(9):1184.","DOI":"10.3390\/brainsci12091184"},{"key":"4176_CR54","doi-asserted-by":"crossref","unstructured":"Sandilands K, Williams A, Rylands AJ. Carer burden in rare inherited diseases: a literature review and conceptual model. Orphanet J Rare Dis. 2022 Dec, 9;17(1):428.","DOI":"10.1186\/s13023-022-02561-w"},{"key":"4176_CR55","doi-asserted-by":"crossref","unstructured":"Polsinelli AJ. Care partner burden and support services in dementia. Continuum: Lifelong Learn in Neurol. 2024 Dec, 1;30(6):1845\u201362.","DOI":"10.1212\/CON.0000000000001502"},{"key":"4176_CR56","doi-asserted-by":"crossref","unstructured":"Kanters TA, van der Ploeg AT, Brouwer WB, Hakkaart L. The impact of informal care for patients with pompe disease: an application of the CarerQol instrument. Mol Genet and Metab. 2013 Nov, 1;110(3):281\u201386.","DOI":"10.1016\/j.ymgme.2013.07.020"}],"updated-by":[{"DOI":"10.1186\/s13023-026-04480-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000}}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-04176-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-04176-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-04176-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T11:12:43Z","timestamp":1787569963000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13023-025-04176-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4176"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-04176-3","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"assertion":[{"value":"3 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s13023-026-04480-6","URL":"https:\/\/doi.org\/10.1186\/s13023-026-04480-6","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All patients and\/or guardians provided written informed consent before entering into the study. All research was conducted with the approval of the WIRB Western International Review Board- Copernicus Group (IRB Protocol Number: 20240227) granted on January 30\n                      th\n                      , 2024.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients and\/or guardians provided written informed consent for publication of individual data. All research was conducted with the approval of the WIRB Western International Review Board- Copernicus Group (IRB Protocol Number: 20240227) granted on January 30\n                      th\n                      , 2024.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There are no potential conflicts of interest among the authors.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"36"}}